Low-dose salinomycin induces anti-leukemic responses in AML and MLL

Development of anti-cancer drugs towards clinical application is costly and inefficient. Large screens of drugs, efficacious for non-cancer disease, are currently being used to identify candidates for repurposing based on their anti-cancer properties. Here, we show that low-dose salinomycin, a cocci...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Roulston, Gary D.R., Burt, Charlotte L., Kettyle, Laura M.J., Matchett, Kyle B., Keenan, Heather L., Mulgrew, Nuala M., Ramsey, Joanne M., Dougan, Caoifa, McKiernan, John, Grishagin, Ivan V., Mills, Ken I., Thompson, Alexander
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5341990/
https://ncbi.nlm.nih.gov/pubmed/27612428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11866
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares